Heejin Jun
Undergraduate intern (2019. 09 ~ 2020. 02)
Graduate student (2020. 03 ~ present)
아산사회복지재단 의생명과학분야 장학생 선정 (2024)
5. Park, S. G.,# Kim, H. J.,# Lee, H. B., Eom, S., Jun, H., Jang, Y., Park, S. H.* and Kang, S.* Protein cage nanoparticle-based NK cell-engaging nanodrones (NKeNDs) effectively recruit NK cells to target tumor sites and suppress tumor growth. Nano Today, 2024, 54, 102075.
4. Kang, Y., Yeo, M., Choi, H., Jun, H., Eom, S., Park, S. G., Yoon, H., Kim, E.,* and Kang, S.* Lactate Oxidase/vSIRPa Conjugates Efficiently Consume Tumor-produced Lactate and Locally Produce Tumor-necrotic H2O2 to Suppress Tumor Growth. Int. J. Biol. Macromol., 2023, 2023, 231, 123577.
3. Park, S. G., Kim, H., Jun, H., Choi, S. Y., Kim, E.,* and Kang, S.* Directing Ricin-based Immunotoxins with Targeting Affibodies and KDEL Signal Peptide to Cancer Cells Effectively Induces Apoptosis and Tumor Suppression. J. Nanobiotechnology, 2022, 20, 387.
2. Jun, H., Jang, E., Kim, H., Yeo, M., Park, S. G., Lee, J., Shin, K. J., Chae, Y. C. Kang, S.,* and Kim, E.* TRAIL & EGFR Affibody Dual-display on a Protein Cage Nanoparticle Synergistically Suppresses Tumor Growth. J. Control. Release, 2022, 349, 367-378.
1. Kim, H., Jin, S., Choi, H., Kang, M., Park, S. G., Jun, H., Cho, H., and Kang, S.,* Target-Switchable Gd(III)-DOTA/Protein Cage Nanoparticle Conjugates with Multiple Targeting Affibody Molecules as Target Selective T1 Contrast Agents for High-field MRI. J. Control. Release, 2021, 335, 269-280.